Cite

HARVARD Citation

    Oriol, A. et al. (2015). Efficacy and safety of bortezomib-based retreatment at the first relapse in multiple myeloma patients: A retrospective study. Hematology. 20 (7), pp. 405-409. [Online]. 
  
Back to record